NCT07156903 Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer
| NCT ID | NCT07156903 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Prostate Cancer Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Exploratory qualitative survey to assess the needs of patients and their relatives during and after radiotherapy for prostate cancer and their attitudes and wishes regarding prehabilitation measures
Eligibility Criteria
Inclusion Criteria: * Diagnosed Prostate Cancer with curativ intended Radiotherapy * min. 18 years * sufficient knowledge of German language for participation in interviews * Capacity to consent Exclusion Criteria: * age \<18 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07156903 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07156903 currently recruiting?
Yes, NCT07156903 is actively recruiting participants. Contact the research team at franziska.hausmann@charite.de for enrollment information.
Where is the NCT07156903 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT07156903 clinical trial?
NCT07156903 is sponsored by Charite University, Berlin, Germany. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.